-
NAVIGATING THE NEW NICE HEALTHTECH PROGRAMME: PRACTICAL IMPLICATIONS AND STRATEGIC CONSIDERATIONS FOR MARKET ACCESS
Aug 11, 2026, 17:16 PM -
REAL-WORLD CLINICAL INDICATORS PRIOR TO FIRST-LINE TREATMENT INITIATION IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A NORSTELLALINQ CLAIMS AND EHR ANALYSIS
Aug 11, 2026, 17:16 PM -
IDENTIFYING CANDIDATE SURROGATE ENDPOINTS FOR OVERALL SURVIVAL IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: ESTABLISHING INDIVIDUAL-LEVEL SURROGACY
Aug 11, 2026, 17:16 PM -
INPATIENT BURDEN OF INFLUENZA AND INFLUENZA-LIKE ILLNESS AMONG ADULTS IN GERMANY, 2022-2025
Aug 11, 2026, 17:16 PM -
PUBLISHED CLINICAL AND ECONOMIC EVIDENCE AS A PREREQUISITE FOR ASSESSING THE VALUE OF CONTINUOUS GLUCOSE MONITORING SYSTEMS (CGM)
Aug 11, 2026, 17:16 PM -
MOMELOTINIB RESULTS IN COST SAVINGS VS RUXOLITINIB FOR PATIENTS WITH MYELOFIBROSIS AND MODERATE TO SEVERE ANAEMIA
Aug 11, 2026, 17:16 PM -
MANAGEMENT OF POST-SURGICAL PERIPHERAL NEUROPATHIC PAIN IN ADULTS: A FRENCH SURVEY
Aug 11, 2026, 17:16 PM -
XLGEN: A STRUCTURE-FIRST KNOWLEDGE GRAPH FRAMEWORK FOR AI-ASSISTED QUALITY CONTROL OF EXCEL-BASED BUDGET IMPACT MODELS
Aug 11, 2026, 17:16 PM -
FROM REACTIVE TO PREDICTIVE: A HUMAN-IN-THE-LOOP AI FRAMEWORK FOR ANTICIPATORY PICO SCOPING FOR EU JOINT CLINICAL ASSESSMENTS
Aug 11, 2026, 17:16 PM -
ECONOMIC IMPACT OF RECOMBINANT ACTIVATED FACTOR VII PROPHYLAXIS IN SEVERE GLANZMANN THROMBASTHENIA: A PROSPECTIVE COHORT ANALYSIS FROM SAUDI ARABIA
Aug 11, 2026, 17:16 PM -
HTA BODIES REQUEST FEWER THAN 50% OF GUIDELINE-DEFINED PICOS: EVIDENCE FROM EIGHT EU MARKETS AND LESSONS FOR EU JCA
Aug 11, 2026, 17:16 PM -
PRICING AN ORPHAN THERAPY WHEN COST-UTILITY ANALYSIS IS INFEASIBLE: A PRICE-EFFICACY FRONTIER FOR PRIMARY HYPEROXALURIA TYPE 1 IN MOROCCO
Aug 11, 2026, 17:16 PM -
RESPIRATORY SYNCYTIAL VIRUS- HEALTHCARE RESOURCE UTILIZATION IN BRAZILIAN CHILDREN <5 YEARS: SURVEILLANCE AND HOSPITAL DATA, 2022-2024
Aug 11, 2026, 17:16 PM -
TRANSLATION AND CULTURAL ADAPTATION OF THE EQ-5D-5L BOLT-ON TOOLBOX INTO MODERN STANDARD ARABIC FOR USE IN SAUDI ARABIA
Aug 11, 2026, 17:16 PM -
EXPLICITNESS OF BROADER VALUE ELEMENTS IN ORPHAN DRUG HEALTH TECHNOLOGY ASSESSMENT (HTA): A 12-COUNTRY COMPARATIVE ASSESSMENT IN EUROPE
Aug 11, 2026, 17:16 PM -
GLOBAL HETEROGENEITIES OF TRUST IN SCIENCE, SOCIAL CONSENSUS, AND VACCINE ACCEPTANCE: EVIDENCE FROM THE WELLCOME GLOBAL MONITOR DATA
Aug 11, 2026, 17:16 PM -
EPIDEMIOLOGY, PROGNOSIS, AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN HER2-POSITIVE, RAS WILD-TYPE (WT), METASTATIC COLORECTAL CANCER (MCRC): A LITERATURE REVIEW AND QUALITATIVE SYNTHESIS
Aug 11, 2026, 17:16 PM -
EVALUATING THE IMPACT OF COENZYME Q10 ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE: A PATIENT-REPORTED OUTCOMES STUDY
Aug 11, 2026, 17:16 PM -
IRON-AI - IRON REPLACEMENT OPTIONS NAVIGATOR: AN R/SHINY-BASED ARTIFICIAL INTELLIGENCE TOOL TO SUPPORT DECISION-MAKING IN INTRAVENOUS IRON THERAPY
Aug 11, 2026, 17:16 PM -
REAL-WORLD POLICY IMPACT OF A TUMOR-AGNOSTIC CLINICAL GENE PANEL FOR ADVANCED CANCERS
Aug 11, 2026, 17:16 PM
